Affordable Access

deepdyve-link
Publisher Website

Review of the Omnipod® 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes.

Authors
  • Cobry, Erin C1
  • Berget, Cari1
  • Messer, Laurel H1
  • Forlenza, Gregory P1
  • 1 University of Colorado School of Medicine, Barbara Davis Center, Aurora, CO 80045 USA.
Type
Published Article
Journal
Therapeutic Delivery
Publisher
"Future Science, LTD"
Publication Date
Aug 01, 2020
Volume
11
Issue
8
Pages
507–519
Identifiers
DOI: 10.4155/tde-2020-0055
PMID: 32723002
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Type 1 diabetes (T1D) is a medical condition that requires constant management, including monitoring of blood glucose levels and administration of insulin. Advancements in diabetes technology have offered methods to reduce the burden on people with T1D. Several hybrid closed-loop systems are commercially available or in clinical trials, each with unique features to improve care for patients with T1D. This article reviews the Omnipod® 5 Automated Glucose Control System Powered by Horizon™ and the safety and efficacy data to support its use in the management of T1D.

Report this publication

Statistics

Seen <100 times